Search clinical trials for: GSK1358820

Total 8 results

GlaxoSmithKline

Completed

GSK1358820 (Botulinum Toxin A) PhIII DB & OL Study in Patients With Axillary Hyperhidrosis

Hyperhidrosis

Japan
GlaxoSmithKline

Completed

Study Of GSK1358820 In Patients With Post-Stroke Upper Limb Spasticity

Cerebrovascular Accident | Post-Stroke Spasticity

Japan
GlaxoSmithKline

Completed

Study of GSK1358820 In Patients With Post-Stroke Lower Limb Spasticity

Cerebrovascular Accident | Post-Stroke Spasticity

Japan
GlaxoSmithKline

Completed

Efficacy and Safety Study of GSK1358820 in Japanese Patients With Urinary Incontinence Due to Neurogenic Detrusor Overactivity

Urinary Bladder, Overactive

Japan
GlaxoSmithKline

Completed

Efficacy and Safety of GSK1358820 in Subjects With Overactive Bladder

Urinary Bladder, Overactive

Japan
GlaxoSmithKline

Completed

Efficacy and Safety of GSK1358820 (Botulinum Toxin Type A) in Patients With Strabismus

Strabismus

Japan
GlaxoSmithKline

Completed

A Phase III Study to Evaluate the Efficacy and Safety of GSK1358820 in Subjects With Post-stroke Upper Limb Spasticity

Spasticity, Post-Stroke

Japan
GlaxoSmithKline

Completed

A Multicenter, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Safety of GSK1358820 (Botulinum Toxin Type A) in Chinese Subjects With Post-stroke Upper Limb Spasticity

Cerebrovascular Accident

China

3

Subscribe